Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
115.22 -5.23  -4.34% NASDAQ Jan 30, 8:00PM BATS Real time Currency in USD

Synageva BioPharma Price to Book Value:

7.366 for Jan. 30, 2015

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Price to Book Value Chart

Export Data
Save Image

Synageva BioPharma Historical Price to Book Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Jan. 30, 2015 7.366
Jan. 29, 2015 7.700
Jan. 28, 2015 7.372
Jan. 27, 2015 7.656
Jan. 26, 2015 7.730
Jan. 23, 2015 7.600
Jan. 22, 2015 7.550
Jan. 21, 2015 7.419
Jan. 20, 2015 7.387
Jan. 16, 2015 7.026
Jan. 15, 2015 6.964
Jan. 14, 2015 7.107
Jan. 13, 2015 7.021
Jan. 12, 2015 7.069
Jan. 9, 2015 6.937
Jan. 8, 2015 6.776
Jan. 7, 2015 6.650
Jan. 6, 2015 6.021
Jan. 5, 2015 6.423
Jan. 2, 2015 6.018
Dec. 31, 2014 5.932
Dec. 30, 2014 5.792
Dec. 29, 2014 5.957
Dec. 26, 2014 5.835
Dec. 24, 2014 5.735
   
Dec. 23, 2014 5.737
Dec. 22, 2014 6.093
Dec. 19, 2014 6.102
Dec. 18, 2014 6.073
Dec. 17, 2014 6.139
Dec. 16, 2014 5.586
Dec. 15, 2014 5.569
Dec. 12, 2014 5.834
Dec. 11, 2014 5.834
Dec. 10, 2014 5.598
Dec. 9, 2014 5.670
Dec. 8, 2014 5.442
Dec. 5, 2014 5.420
Dec. 4, 2014 5.227
Dec. 3, 2014 5.200
Dec. 2, 2014 5.228
Dec. 1, 2014 5.047
Nov. 28, 2014 5.191
Nov. 26, 2014 5.252
Nov. 25, 2014 5.147
Nov. 24, 2014 5.055
Nov. 21, 2014 4.778
Nov. 20, 2014 4.543
Nov. 19, 2014 4.576
Nov. 18, 2014 4.874

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Get data for
Advertisement

GEVA Price to Book Value Benchmarks

Companies
Ultragenyx Pharmaceutical 9.283
Regado Biosciences 1.430
PTC Therapeutics 8.012

GEVA Price to Book Value Range, Past 5 Years

Minimum 0.7259 Sep 12 2011
Maximum 10.47 Mar 27 2012
Average 4.090

GEVA Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("GEVA", "price_to_book_value")
  • Last 5 data points: =YCS("GEVA", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.